These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29784841)

  • 1. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.
    Quang NN; Chavchich M; Anh CX; Birrell GW; van Breda K; Travers T; Rowcliffe K; Edstein MD
    Am J Trop Med Hyg; 2018 Jul; 99(1):65-72. PubMed ID: 29741150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiplasmodial activity of the carboxylic acid metabolite of piperaquine and its pharmacokinetic profiles in healthy volunteers.
    Liu H; Zhou H; Xing J
    J Antimicrob Chemother; 2024 Jan; 79(1):78-81. PubMed ID: 37965893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the component in Artemisia annua L. leading to enhanced antiplasmodial potency of artemisinin via regulation of its metabolism.
    Cai TY; Zhang YR; Ji JB; Xing J
    J Ethnopharmacol; 2017 Jul; 207():86-91. PubMed ID: 28642094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gender-related variability in the pharmacokinetics and antiplasmodial activity of naphthoquine in rodents.
    Xie Y; Liu H; Sun Y; Xing J
    Malar J; 2020 Feb; 19(1):71. PubMed ID: 32054478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
    Moore BR; Batty KT; Andrzejewski C; Jago JD; Page-Sharp M; Ilett KF
    Antimicrob Agents Chemother; 2008 Jan; 52(1):306-11. PubMed ID: 17984231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of malaria-induced alteration of metabolism on piperaquine disposition in Plasmodium yoelii infected mice and predicted in malaria patients.
    Xie Y; Zhang Y; Lin F; Chen X; Xing J
    Int J Antimicrob Agents; 2024 Jul; 64(1):107209. PubMed ID: 38761871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
    Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human urinary metabolites of the antimalarial piperaquine.
    Tarning J; Bergqvist Y; Day NP; Bergquist J; Arvidsson B; White NJ; Ashton M; Lindegårdh N
    Drug Metab Dispos; 2006 Dec; 34(12):2011-9. PubMed ID: 16956956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto-induction of phase I and phase II metabolism of artemisinin in healthy Chinese subjects after oral administration of a new artemisinin-piperaquine fixed combination.
    Zang M; Zhu F; Li X; Yang A; Xing J
    Malar J; 2014 Jun; 13():214. PubMed ID: 24889062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperaquine pharmacodynamics and parasite viability in a murine malaria model.
    Moore BR; Ilett KF; Page-Sharp M; Jago JD; Batty KT
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2707-13. PubMed ID: 19380600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
    Patel K; Batty KT; Moore BR; Gibbons PL; Kirkpatrick CM
    J Antimicrob Chemother; 2014 Aug; 69(8):2155-63. PubMed ID: 24777899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperaquine: a resurgent antimalarial drug.
    Davis TM; Hung TY; Sim IK; Karunajeewa HA; Ilett KF
    Drugs; 2005; 65(1):75-87. PubMed ID: 15610051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
    Hoglund RM; Workman L; Edstein MD; Thanh NX; Quang NN; Zongo I; Ouedraogo JB; Borrmann S; Mwai L; Nsanzabana C; Price RN; Dahal P; Sambol NC; Parikh S; Nosten F; Ashley EA; Phyo AP; Lwin KM; McGready R; Day NP; Guerin PJ; White NJ; Barnes KI; Tarning J
    PLoS Med; 2017 Jan; 14(1):e1002212. PubMed ID: 28072872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism is not a Major Contributor to the Toxicity of Piperaquine, a Long-acting Antimalarial Agent in Artemisinin-based Combination Therapy.
    Zhang L; Liu Z; Zhang Y; Xie Y; Xing J
    Curr Drug Metab; 2021; 22(10):824-834. PubMed ID: 34602032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
    Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.